Director/PDMR Shareholding

16 July 2014

Synergy Health plc ("Synergy", the "Company", or the "Group")

Director/PDMR Shareholding

The Company announces the following transactions by a person discharging managerial responsibilities ("PDMR"), in Synergy Health plc ordinary shares of 0.625 pence each ("Ordinary Shares") and the consequent allocations of Ordinary Shares to the LTIP Co-Invest scheme:

Dr Richard Steeves, Chief Executive Officer, exercised options over 30,364 Ordinary Shares under the Company's LTIP scheme. These Ordinary Shares have been retained by Dr Steeves and 29,274 shares have been allocated to the LTIP Co-Invest Scheme. As a result of the allocation to the Company's Co-Invest Scheme, Dr Steeves has been granted an LTIP Co-Invest option of 58,548 options. Following the transaction Dr Steeves has an interest in 1,862,836 Ordinary Shares, representing 3.16% of the Company's issued share capital.

The LTIP Co-Invest arrangement requires that the participant to whom the award is to be made invests in Ordinary Shares in the Company and continues to hold those Ordinary Shares throughout the three year measurement period. At the end of the measurement period, depending upon the growth in earnings per share of the Company over the measurement period, the participant will receive a number of "matching" shares at nominal value under the LTIP Co-Invest.

For further information:

Tim Mason, Group Company Secretary +44 (0) 1793 891 862